A sheet-mask client once brought their Taiwanese cosmetic product notification printout to a meeting and asked, “can we use this in the US?” The honest answer: no. A few years ago nobody would even have asked, because cosmetics were famously FDA’s lightest-touch category — barely any registration, no listing, few reports. MoCRA — the Modernization of Cosmetics Regulation Act — ended that era. Cosmetic regulation has moved visibly toward the drug model, and the old “pack it and ship it” approach now has compliance steps that must be completed first.
The five things MoCRA requires
In shipping order — missing any one can strand the goods:
- Facility registration: plants that manufacture or process cosmetics register with FDA, renewed every two years — not a one-time filing
- Product listing: every product marketed in the US is listed with FDA, ingredients disclosed
- Safety substantiation: adequate evidence that the product is safe under normal use, producible on request
- A US responsible person: the manufacturer, packer or distributor named on the label, who owns the listing and adverse-event reporting — without this role, nobody in the US “answers to FDA” for your product
- Adverse event reporting: serious events reported within deadlines, records retained
Note the split: the first four are pre-shipment items; the last is an ongoing post-market duty. Taiwanese factories tend to fixate on the label and miss the two factory-side actions — registration and listing.
The small-business exemption: real, but do not lean on it
MoCRA carves out partial exemptions for small businesses (mainly registration and listing), but the thresholds are low, and categories like eye-area products and items with prolonged mucosal contact are excluded. The more practical problem: your US channel and retail platforms usually do not care whether you qualify — their onboarding asks for registration and listing proof outright. Treating the exemption as a free pass mostly gets you stopped at the channel, not at FDA.
The three traps Taiwanese makers hit
Trap one: treating the Taiwan notification as an equivalent. Taiwan’s product notification and MoCRA’s registration and listing are separate systems with no mutual recognition. Taiwanese paperwork is evidence your internal files are in order — it replaces nothing on the US side.
Trap two: incomplete INCI labeling. The US requires ingredients declared by INCI names. Taiwanese packaging often uses Chinese names, trade names, or lists only key actives. An incomplete or wrongly-named ingredient list is straightforward misbranding.
Trap three: shipping without a responsible person. With no US-side role accountable to FDA on the label, the listing and adverse-event duties have nowhere to attach. This is pre-shipment architecture, not paperwork to backfill after arrival.
How SKYCARGO takes it from there
SKYCARGO INC holds FDA and USDA agent status and can act as your Importer of Record and consignee. On cosmetics projects we check three things before booking: the status of facility registration and product listing, the completeness of INCI labeling, and who will serve as the US responsible person. Once the structure is confirmed, we ship; on arrival the same team clears customs, meets any examination, and moves goods into the warehouse and out. Logistics and compliance on one line — so you do not discover a missing structural piece after the goods reach port. Personal-use skincare belongs with Shiptw consolidation.
Taking a beauty brand into the US? Send us your product list and current labels and we will reply within one business day with your MoCRA gap list.
This article summarizes MoCRA requirements for reference only. Confirm specifics against current FDA publications and formal regulatory advice for individual cases.
